ArticleClinical breast cancer2024

Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.

Jayasree Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.